Form 8-K - Current report:
SEC Accession No. 0001104659-25-107740
Filing Date
2025-11-06
Accepted
2025-11-06 16:15:14
Documents
15
Period of Report
2025-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2530323d1_8k.htm   iXBRL 8-K 32701
2 EXHIBIT 99.1 tm2530323d1_ex99-1.htm EX-99.1 61229
7 GRAPHIC tm2530323d1_ex99-1img001.jpg GRAPHIC 20018
  Complete submission text file 0001104659-25-107740.txt   347241

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20251106.xsd EX-101.SCH 3892
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20251106_def.xml EX-101.DEF 27149
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20251106_lab.xml EX-101.LAB 37086
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20251106_pre.xml EX-101.PRE 25773
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2530323d1_8k_htm.xml XML 6039
Mailing Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 (650) 457-1978
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 251458493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)